JMP Securities Downgrades Iovance Biotherapeutics (LSE:0JDK)
10/5 04:02
Fintel reports that on May 9, 2025, JMP Securities downgraded their outlook for Iovance Biotherapeutics (LSE:0JDK) from Market Outperform to Market Perform....
10/5 04:02
Fintel reports that on May 9, 2025, JMP Securities downgraded their outlook for Iovance Biotherapeutics (LSE:0JDK) from Market Outperform to Market Perform....